- Idelalisib in the treatment of patients with follicular lymphoma2015 | Faculty of Medicine in Hradec Králové
- Case reports from clinical practice: experience with idelalisib treatment in patients with chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Idelalisib in the treatment of chronic lymphocytic leukaemia2015 | First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-313-0124Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. GS-US-312-0133Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. GS-US-312-0115Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-313-0125Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GS-US-312-0123Publication without faculty affiliation
- Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey2020 | Publication without faculty affiliation
- Clinical case: idelalisib-induced immunoglobulin flare2017 | Central Library of Charles University, Third Faculty of Medicine
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Treatment of repeatedly relapsing chronic lymphocytic leukemia2018 | Faculty of Medicine in Hradec Králové
- Small Molecules in the Treatment of Chronic Lymphocytic Leukemia in 2015 and in the Near Future2015 | First Faculty of Medicine
- Treatment of elderly and comorbid patients with chronic lymphocytic leukemia2017 | Faculty of Medicine in Hradec Králové
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- New drugs in the treatment of B-lymphoproliferative disorders - highlights from ICML congress in Lugano, June 20132013 | Faculty of Medicine in Hradec Králové
- The terapeutic Options for ""Slow- go"" Patients with Chronic Lymphocytic Leukemia2015 | Faculty of Medicine in Hradec Králové
- Richter transformation of chronic lymphocytic leukaemia in the era of treatment with B-cell signalling pathway inhibitors2020 | First Faculty of Medicine
- Nové léčebné postupy u chronické lymfocytární leukemie2017 | First Faculty of Medicine
- New drugs for the treatment of chronic lymphocytic leukemia2015 | First Faculty of Medicine
- Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial2017 | Faculty of Medicine in Hradec Králové
- ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia2020 | Central Library of Charles University
- Practical approach to management of chronic lymphocytic leukemia2016 | Faculty of Medicine in Hradec Králové
- Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge2016 | Faculty of Medicine in Hradec Králové
- Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions2016 | Faculty of Medicine in Hradec Králové
- Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study2018 | Publication without faculty affiliation
- Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells2020 | First Faculty of Medicine, Second Faculty of Medicine
- Targeting phosphatidylinositol 3 kinase-beta and -delta for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma2020 | First Faculty of Medicine
- Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation2017 | Publication without faculty affiliation
- Recommendations for chronic lymphocytic leukaemia diagnosis and therapy 20212021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
